The 61 rating InvestorsObserver gives to Travere Therapeutics Inc (TVTX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 85 percent of stocks in the Biotechnology industry, TVTX’s 61 overall rating means the stock scores better than 61 percent of all stocks.
TVTX has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on TVTX!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 61 would rank higher than 61 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Travere Therapeutics Inc Stock Today?
Travere Therapeutics Inc (TVTX) stock is up 1.63% while the S&P 500 has fallen -0.9% as of 1:01 PM on Monday, Apr 25. TVTX is up $0.45 from the previous closing price of $27.66 on volume of 129,179 shares. Over the past year the S&P 500 has risen 1.09% while TVTX is up 13.30%. TVTX lost -$3.01 per share the over the last 12 months.
Click Here to get the full Stock Report for Travere Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
